Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-042328
Filing Date
2017-06-29
Accepted
2017-06-29 16:44:46
Documents
1
Period of Report
2017-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4180
  Complete submission text file 0001209191-17-042328.txt   5667
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 715 STREET ROAD NEW HOPE PA 18938
Business Address
Zakrzewski Joseph S (Reporting) CIK: 0001331852 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 17938847